chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report from a contactable nurse. A patient of unspecified age ethnicity and gender received TRUMENBA, via an unspecified route of administration on an unspecified date at single dose. The patient medical history and concomitant medications were not reported. The patient experienced lot of body aches, joint pain, nausea, dizziness, chills all on an unspecified date with outcome of not recovered. The patient reported that when they works out, it got worse. Follow-up (18)AUG2016): Follow-up attempts are completed. No further information is expected.
Pt recv vax on 10/26/98; 12 hr post vax pt exp headache, diarrhea & achiness x 12 hr
A warm burning sensation upper back by shoulder on left side where vaccination was given, stiffness in neck. pain in buttock area, shortness of breath.
This spontaneous report was received from a medical assistant concerning an unspecified patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On an unknown date from 02-APR-2018 to 15-MAY-2018, the patient was vaccinated with an improperly stored dose of VARIVAX (Lot #: N021315, Exp Date: 07-AUG-2019) (Lot#: N029632, Exp Date: 23-OCT-2019) or (Lot#: N030571, Exp Date: 31-OCT-2019) for prophylaxis, which had a temperature excursion of 6.1F for 5 minutes. Previous temperature excursion was 5.9 F for 45 minutes. The digital data logger was involved in recording the temperature excursion. The vaccine was reconstituted with properly stored dose of sterile diluent (MERCK) (no more information was provided). No adverse effect was reported. No product quality complaint was involved. This is one of the several reports from the same source. Sender's Comments: US-009507513-1805USA009899:Original Case : 1805USA006787; US-009507513-1805USA009900:Original Case : 1805USA006787; US-009507513-1805USA009901:Original Case : 1805USA006787; US-009507513-1805USA009902:Original Case : 1805USA006787; US-009507513-1805USA009903:Original Case : 1805USA006787; US-009507513-1805USA009904:Original Case : 1805USA006787; US-009507513-1805USA009905:Original Case : 1805USA006787; US-009507513-1805USA009906:Original Case : 1805USA006787; US-009507513-1805USA009907:Original Case : 1805USA006787; US-009507513-1805USA009908:Original Case : 1805USA006787; US-009507513-1805USA009909:Original Case : 1805USA006787; US-009507513-1805USA009910:Original Case : 1805USA006787; US-009507513-1805USA009911:Original Case : 1805USA006787; US-009507513-1805USA009912:Original Case : 1805USA006787; US-009507513-1805USA009913:Original Case : 1805USA006787; US-009507513-1805USA009914:Original Case : 1805USA006787; US-009507513-1805USA009915:Original Case : 1805USA006787; US-009507513-1805USA009916:Original Case : 1805USA006787; US-009507513-1805USA009917:Original Case : 1805USA006787; US-009507513-1805USA009918:Original Case : 1805USA006787; US-009507513-1805USA009919:Original Case : 1805USA006787; US-009507513-1805USA009920:Original Case : 1805USA006787; US-009507513-1805USA009921:Original Case : 1805USA006787; US-009507513-1805USA009922:Original Case : 1805USA006787; US-009507513-1805USA009923:Original Case : 1805USA006787; US-009507513-1805USA009924:Original Case : 1805USA006787; US-009507513-1805USA009925:Original Case : 1805USA006787; US-009507513-1805USA009926:Original Case : 1805USA006787; US-009507513-1805USA009927:Original Case : 1805USA006787; US-009507513-1805USA009928:Original Case : 1805USA006787; US-009507513-1805USA009929:Original Case : 1805USA006787; US-009507513-1805USA009930:Original Case : 1805USA006787; US-009507513-1805USA009931:Original Case : 1805USA006787; US-009507513-1805USA009932:Original Case : 1805USA006787; US-009507513-1805USA006787.
The organization was giving vaccines.  Patient asked mom to complete paperwork for Covid Vaccine and asked was the child under 12-yrs old. Mom and child said she was 12. Pfizer vaccine was given to child. While completing the Covid Vaccine record card it was discovered that child was only 11 almost 12 and thought it was no problem. Never had any problem.
PC from mom stating pt continuous crying x 1.5 hrs; w/ episodes of limpness;was advised to seek MD help, cont apap as inst earlier;pt see by MD & adm to hosp;to f/u w/ appt as scheduled 14feb95;pt home now w/ no obvious problems;
continued injection site pain more than 4 weeks after injection; This spontaneous report was received from a consumer and refers to a 68-year-old male patient. There was no information about the patient's concurrent conditions, concomitant therapies, drug reactions, allergies or medical history provided.  On an unknown date, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, for prophylaxis (exact dose, route of administration, anatomical site, lot # and expiry date were not provided).  On an unknown date (reported as "more than 4 weeks after injection"), the patient was experiencing continued injection site pain. There was no redness or swelling. It was unknown if any treatment was received for this event. The patient had an X-ray performed which did not show any abnormality or foreign object. The outcome of the event was not reported.  The causal relationship between the event and the suspect product was not provided by the reporter.
Flu vaccine given 9-12-12 - redness to injection site Lt. deltoid - redness around neck & under chin.
PREVNAR vaccination right deltoid 1-7-16. Redness and swelling at site, required systemic steroids (prednisone 20mg daily for 5 days).
Systemic: Dizziness / Lightheadness-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Nausea-Medium, Additional Details: Patients BP was 120/87 after the 15 minute period. Symptoms resolved after giving the patient water.
her arm started itching,; arm turned red; arm was a bit swollen; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PRURITUS (her arm started itching,), ERYTHEMA (arm turned red) and PERIPHERAL SWELLING (arm was a bit swollen) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 20-Mar-2021, the patient experienced PRURITUS (her arm started itching,), ERYTHEMA (arm turned red) and PERIPHERAL SWELLING (arm was a bit swollen). At the time of the report, PAIN IN EXTREMITY (Sore arm), PRURITUS (her arm started itching,), ERYTHEMA (arm turned red) and PERIPHERAL SWELLING (arm was a bit swollen) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No contaminant products were reported. No treatment information was reported.
Patient was administered GARDASIL (her second dose) as well as FLUZONE flu shot. Patient experienced fever, shakiness, weak, nausea and dry heaving. patient said she had a similar reaction with her first shot of GARDASIL, but much less severe.
Rash with itching noted on soles of both feet. Client states discomfort with rash. No elevation of temperature.
Woke up in the middle of the night twice with Tingling in my finger tips  even though I was sleeping on my back and not having any pressure on my arms  like you would normally experience if your arm fell asleep? This happened again last night . After waking and moving my hands and fingers the tingling stopped.
Evening after 2nd injection (Friday, March 6, 2021): severe, debilitating pain, specifically in the area of the heart. Went to ER and was given EKG, Chest X-Ray, and blood tests to check for heart attack. Symptoms subsided after a bit. Labs were inconclusive. Sent home. Continued to have lingering aching in the heart region the next day. Throughout the weekend, continued to experience alternating sweats and chills, nausea and increased pain in hip joints causing difficulty to walk.  Stayed home from work on Monday, March 8, 2021 with the same symptoms continuing.  Tuesday, March 9, 2021 began experiencing excruciating thigh and knee pain to the point of barely being able to stand or walk. Returned to the ER where they administered Torodol and pain subsided. Will be seeing primary care physician Tuesday afternoon.
Vaccine given on 4/6/18, on 4/8/18 patient developed a red patch 2 inches below the SHINGRIX injection site. The patch is 3-4 inches in diameter and is an irregular shape. She states it is hot to touch and swollen. On 4/10/18 the patch was gone in the morning then reappeared in the afternoon, the patch has been present since 4/10/18, still hot, red and swollen. It is not blistering.
Arms felt very heavy, fainted, struck head and side of rib cage. Went to primary care physician. Atrial flutter diagnosis. Sent to Emergency Room, admitted to hospital. Converted back to normal sinus rhythm with meds only, no further intervention needed.
Full body rash-erythematous-vesicular 4-5 hrs after injection.
Information has been received from a registered nurse concerning a female who on 29OCT2003 was vaccinated IM with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently, in approximately October 2003, the pt complained of fever 100.3, pain, soreness and redness at the injection site. The pt went to the emergency room for evaluation where she was treated with abx and released. At the time of the report, the pt was "recovering with sequalea". A product quality complaint was not involved. Additional information has been requested.
No adverse eventa occured after first vaccine. Three hours after second vaccination I started to feel adverse reactions. It started with sore throat, tiredness, body ache. Next morning work up with swollen lymph nodes, body ache, tiredness, headache, and the chills. Today feel alot better and adverse reactions have seem to subside.
Narrative:  Patient received Prevnar 20 vaccine on 07/08/2022 and sent secure message to provider on 7/11/22 stating "I think I am having a reaction to the pneumonia vaccine. It's really red, hot to touch and itches.is this normal." Provider advised patient to treat with Benadryl PO and hydrocortisone cream.
Dizziness started within 3 minutes of receiving intranasal vaccine; states dizziness completely subsided by 2:00 PM. 2:07 PM-without apparent discomfort or distress. States feels "good".
Pain in right side that night. Confusion and pain in entire body the next day. Foggy then following two days and another episode of pain on fourth night. Today is day five and feel great.
administered with the vaccine at 15 years old; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administered with the vaccine at 15 years old) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Sep-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administered with the vaccine at 15 years old). On 28-Sep-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (administered with the vaccine at 15 years old) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.
Bad  itchy rash and severe indigestion.   Cardiac surgeon recommended 40 mg Pepcid AC.  This reduced the acid build up  and I was left with the rash
A persistent rash on my right hand that will not heal, most of the time it is an open wound that bleeds and is very painful. The rash on my fourth finger has now taken half of my finger nail off.  My palm always has a sore in the middle and I have to keep it covered or it will open and bleed.
I had previously received the original 2 vaccinations from Moderna, and the first Moderna booster a year before this Pfizer bivalent booster (my side effects from the Moderna booster were similar and much worse but I didn't think to report it last year). After 2 hours the normal aching in arm, pain at injection site, tiredness began. By 12 hours after, skin sensitivity, whole body aches, labored breathing, and extreme fatigue began. By 27 hours after my booster shot, pain in and around my lungs/chest, trouble closing my fist, and dizziness began. By 42 hours after, muscle pain /body aches & skin sensitivity mostly stopped, dizziness became only occasional, fatigue decreased. I couldn't take a deep breath but breathing didn't feel heavy or labored. Sharp pain at injection site remained, but was not worse and didn?t include redness or swelling. All side effects subsided on day 5, but from day 6 on I've had bouts of dizziness, nausea, and soreness/tightness in my chest/lungs whenever I don't get enough sleep, or when I over exert myself (it seems I get tuckered out very easily now, so this happens either daily or about every other day). It's been a little over 2 weeks since my shot. I only got 5 hours of sleep today, and that was enough to trigger chest/lung pain and difficulty breathing today.
This spontaneous report was received from a pharmacy intern, referring to a 16 year old patient of unknown gender. No information was provided regarding the patient's medical history, concurrent conditions and concomitant medications. On 02-OCT-2018, the patient received the first dose of GARDASIL 9 lot # R010596 (expiration date: 11-DEC-2020) for prophylaxis (strength, frequency and route of administration were not reported). Then on 30-MAR-2019, approximately 6 months apart from the first dose the patient received the second of GARDASIL 9, for prophylaxis (strength, frequency, route of administration, lot number and expiration date were not reported)(inappropriate schedule of vaccine administered). No adverse effects were reported.
Uncomplicated first and only pregnancy - 30w1d at time of vaccination - due date 6/9/21 - at routine prenatal appointment on next day, blood pressure was elevated: 140/96, 140/98, 146/82, 145/90. Concern for pre-eclampsia, hospital monitoring required.
Headache, joint pain in knees, fingers and neck; tenderness at injection site, fatigue, cough, scratchy throat
Patient states that the injection was placed too high and she felt it being injected into her bursa instead of her deltoid. She has been in pain since her injection, can't sleep, can't lift with that arm, pain 8-9 out of 10. She has been on rest and motrin, with no relief.
Headache, Fever 100.4, Body aches, from 2/1-2/2
Patient presented to medical for concerns of right sided radiating neck/shoulder pain. Patient noticed a lump on his neck just before deciding to seek medical evaluation. The pain initially started 3 days after his first Covid vaccine and was followed by night sweats and SOB which spontaneously subsided after one night. The neck/shoulder pain is still present. Noticed a single swollen cervical lymph node that was very tender to palpation. No other concerns found or surrounding LND.
Started with hoarse voice. Progressed into cough with little mucus being coughed up, but lots of "sticky goop" in lungs. Difficulty sleeping due to cough and noise in lungs.
Pt. recieved vaccine greater than 12 hours after being drawn up. MD contacted pt. pt. declines revaccination. no adverse event
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The patient had no known allergies. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Feb2023, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Feb2023) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 for which patient received PF-07321332, ritonavir (PAXLOVID) from to 07Feb2023 to 11Feb2023. The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.
Rash all over body. Rash also on both cheeks. Face x2d. Patient was initially seen at Peds 2/4/08. Follow up with us on 2/7/08. Dr. Rx'd Triamcinolone for rash, and Tylenol for fever
Pain at the injection site; Swelling at the injection site; Stiffness at the injection site; Dry cough; Fatigue; Body aches; Chills; Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150), via an unspecified route of administration in the left arm on 07Apr2021 at 08:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. The patient had no past medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medication within two weeks of the vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 08Apr2021 at 08:00, the patient experienced pain, swelling, stiffness at the injection site, dry cough, fatigue, nausea, chills and body aches started approximately 24 hours after the injection (as reported). The adverse events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events pain at the injection site, swelling at the injection site, stiffness at the injection site, dry cough, fatigue, nausea, chills and body aches was not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Patient receive  dose #1 of Moderna vaccine. Patient is under 18 years old. Patient was kept for about 1 hour to monitor for side effects. Patient did not present with any side effects post vaccination.
Fever of unknown origin and encephalopathy. Rapid neurological and respiratory decline of unknown origin.
No issue with first vaccination on 12/30/20. 2nd vaccine on 1/21/21.  Started with a single "spot" on abdomen on 2/1/21, has increased to now cover skin from neck to upper thighs.  Went to PCP and instructed to take current anti-histamine PO and to get OTC steroid (Cortisol 1%) cream with no relief to date.  Did not follow up until 3/2/21 because thought it would go away.  Rash stable X7 days.  Diagnosed with pityriasis rosea.  Derm appointment on 3/15/21.
Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 12-Apr-2022; Expired vaccine administered to 155 patients; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients) and PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 12-Apr-2022) in a 72-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 12-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 12-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients) and PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 12-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The vial was initially stored in the refrigerator on 04-Apr-2022. The vial did not undergo any temperature excursions. It was reported that pharmacist thought that the vaccine was expired in Jun-2022, however it was expired on 01-Apr-2022.  No treatment information was reported.
Became dizzy, felt very odd, vision changes, headache on top of head.  I waited for symptoms to pass, and informed hospital staff that I wasn't feeling well.  Sat in a recliner.  Blood pressure check revealed bp of 210/110, which is extremely unusual for me.  I waited and drank juice and water, bp came down some what, but has remained high ever since.  I have never had high blood pressure before.
Swelling at site of injection, very large local reaction x 72 hours, involved 1/2 the cir of arm.
This spontaneous report was received from a certified medical assistant and refers to an unspecified number of patients, of unknown age and gender. Medical history and concurrent conditions were not reported. The medical assistant reported that on an unknown date, the patients were vaccinated with improperly stored doses of ROTATEQ oral, lot#: K017526, expiration date: 12-JUN-2016. Concomitant therapy was not reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Have servere pain and tingling. Can't move or lift arm without help of other hand.  Still pain two days later
Fever to 102, headache, abdominal pain starting 7 am day after vaccine. Symptomatic support - TYLENOL, IBU prn, push fluids OTC,
1st Kinrix however patient has received 5 Dtap total and 4 Polio vaccines.  Per pediatric call nurse RN : Mom reports that the same night , his L thigh was very swollen and red and he was unable to walk. Denies fever  or drainage from the injection site. Redness and swelling has decreased by 50% since. Has a mild rash on his inner thigh . Patient is currently doing better , he still has some pain but he is able to walk slowly. Denies any other symptoms . Med: Ibuprofen.
Started screaming and wouldn't bear weight on leg screams when you touch her leg and won't move it.
This writer recognized the Lot# of the given Hep B Vx was corresponding to pediatric Vx stock. This was verified with another nurse and brought to the attention of the HD. Pt was immediately contacted about dosage discrepancy and that administration of second 0.5mL dose of Hep B Vx would be necessary to complete a full adult dose (1 ml) of Hep B Vx. Pt arrived at clinic in timely fashion and received the additional Vx and has received full adult coverage for the Hep B (2) Vx. Pt has 3rd dose left to complete full 3 dose course for Hep B. Pt. tolerated administration well.
This spontaneous report was received from a pharmacist refers to a 19 year old patient. On 19-JUN-2013, the patient was vaccinated with an expired dose of 0.5 ml GARDASIL, (lot # 1569Z, expiry date 05-APR-2013). Concomitant medications were not reported. No adverse effects were reported. Additional information has been requested.